Answers are grounded in this paper and cite their sources.
Considering the importance of neuroinflammation and neurodegeneration in the pathophysiology of major depressive disorder (MDD), peripheral blood biomarkers are promising for the prediction of diagnosis and treatment outcomes. We aimed to elucidate the neuroinflammatory pathophysiology of depression by evaluating serum levels of FAM19A5 as a new biomarker of inflammatory activation, proinflammatory cytokines, brain-derived neurotrophic factor (BDNF), and oxidative stress parameters.
No takes yet. Share an insight, caveat, or question.
Uzun et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: